COVID–19 Vaccine Accountability Act
Official title: To amend title III of the Public Health Service Act to eliminate immunity for manufacturers of COVID-19 vaccines, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
COVID-19 Vaccine Accountability Act
This bill excludes manufacturers of a mandated COVID-19 vaccine from certain liability protections that apply to manufacturers of medical countermeasures (i.e., medical products that may be used to treat, prevent, or diagnose conditions associated with emerging infectious diseases or chemical, biological, radiological, or nuclear agents). It also retroactively limits to $10,000 the liability of the United States for a death or injury caused by a COVID-19 vaccine administered on or after January 1, 2020.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6282: COVID–19 Vaccine Accountability Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6282/
"H.R. 6282: COVID–19 Vaccine Accountability Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6282/.
H.R. 6282, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6282/.
[H.R. 6282: COVID–19 Vaccine Accountability Act](https://openamerica.io/bill/117-HR-6282/)